Ban on stem-cell research puts U.S. at disadvantage



It's time for President Bush to reconsider his ban on federal funding for important human stem-cell research.
The ban was announced early in the Bush presidency, without much thought or consultation. He billed it as a compromise, but the level of compromise was overstated.
Under the Bush doctrine, the federal government would fund the research on only 78 colonies of stem cells that were in existence before Aug. 9, 2001.
Since then, there have been developments that indicate the administration should rethink its policy and loosen the restrictions on federally funded research.
As The Washington Post reports, of those 78 colonies only 15 are available to researchers, with another eight possibly to come. The rest, for a number of reasons, are unusable or unavailable. And scientists say that replicating a stem-cell line over and over increases the chances of abnormalities.
Being left behind
And while U.S. research is being hampered by a lack of access to adequate stem-cell material, other industrialized nations are forging ahead.
Even though private foundations are pursuing research, in competition against the rest of the world's scientific community, no nation's researchers -- not even those of the United States -- can compete with one arm tied behind their backs.
Embryonic stem cells can replicate almost any cell or tissue in the body, offering the potential -- with far more research to be done -- to treat and even cure diabetes, Parkinson's disease, Alzheimer's and spinal injuries.
But there is some opposition to any program that would encourage or fund the destruction of human embryos, even when the embryos contain only a handful of cells.
The concept that life begins at the moment of conception, even if that conception takes place in a laboratory dish, is a belief held by some religions, but certainly not all. It is not a belief that should dominate government policy on an important scientific issue such as stem cell research.
A Harvard team led by Douglas Melton has announced that it created 17 new stem-cell lines from 344 excess frozen embryos supplied by a Boston fertility clinic with the consent of the owners. The researchers will use the new lines to continue their work of attempting to make insulin-producing pancreatic cells.
Funding source
Melton's funding came from Harvard University, the Juvenile Diabetes Research Foundation and the Howard Hughes Medical Institute. Melton's inspiration comes from having a 12-year-old son and 16-year-old daughter, both of whom have diabetes.
"When my son was diagnosed, I did what any parent does. I asked myself, 'What am I going to do about this?'," Melton said.
Melton chose to pursue stem cell research to help his children and hundreds of thousands of other children. Other researchers should have the same option to pursue important, life-saving and life-enhancing research without having to limit themselves to private foundation funding.
The government of the United States should be a full partner in stem-cell research. because it is the only way for this nation to remain in the forefront of legitimate medical research and because it has the potential to help millions of American citizens.